- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- hetero-15-15-15-15-mer
- Ligands
- 15 x ILE- SER- GLU- VAL: POLIOVIRUS TYPE 3 (SUBUNIT VP1)(Non-covalent)
- 15 x W71: 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE(Non-covalent)
W71.2: 17 residues within 4Å:- Chain A: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain C: A.24
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:Y.111, A:F.133, A:Y.158, A:Y.158, A:Y.158, A:I.193, A:V.195, A:V.195, A:F.237, A:F.237, A:F.237, A:L.240
- pi-Stacking: A:Y.111
W71.5: 17 residues within 4Å:- Chain E: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain G: A.24
13 PLIP interactions:13 interactions with chain E- Hydrophobic interactions: E:Y.111, E:F.133, E:Y.158, E:Y.158, E:Y.158, E:I.193, E:V.195, E:V.195, E:F.237, E:F.237, E:F.237, E:L.240
- pi-Stacking: E:Y.111
W71.8: 17 residues within 4Å:- Chain I: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain K: A.24
13 PLIP interactions:13 interactions with chain I- Hydrophobic interactions: I:Y.111, I:F.133, I:Y.158, I:Y.158, I:Y.158, I:I.193, I:V.195, I:V.195, I:F.237, I:F.237, I:F.237, I:L.240
- pi-Stacking: I:Y.111
W71.11: 17 residues within 4Å:- Chain M: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain O: A.24
13 PLIP interactions:13 interactions with chain M- Hydrophobic interactions: M:Y.111, M:F.133, M:Y.158, M:Y.158, M:Y.158, M:I.193, M:V.195, M:V.195, M:F.237, M:F.237, M:F.237, M:L.240
- pi-Stacking: M:Y.111
W71.14: 17 residues within 4Å:- Chain Q: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain S: A.24
13 PLIP interactions:13 interactions with chain Q- Hydrophobic interactions: Q:Y.111, Q:F.133, Q:Y.158, Q:Y.158, Q:Y.158, Q:I.193, Q:V.195, Q:V.195, Q:F.237, Q:F.237, Q:F.237, Q:L.240
- pi-Stacking: Q:Y.111
W71.17: 17 residues within 4Å:- Chain U: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain W: A.24
13 PLIP interactions:13 interactions with chain U- Hydrophobic interactions: U:Y.111, U:F.133, U:Y.158, U:Y.158, U:Y.158, U:I.193, U:V.195, U:V.195, U:F.237, U:F.237, U:F.237, U:L.240
- pi-Stacking: U:Y.111
W71.20: 17 residues within 4Å:- Chain 0: A.24
- Chain Y: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
13 PLIP interactions:13 interactions with chain Y- Hydrophobic interactions: Y:Y.111, Y:F.133, Y:Y.158, Y:Y.158, Y:Y.158, Y:I.193, Y:V.195, Y:V.195, Y:F.237, Y:F.237, Y:F.237, Y:L.240
- pi-Stacking: Y:Y.111
W71.23: 17 residues within 4Å:- Chain 2: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain 4: A.24
13 PLIP interactions:13 interactions with chain 2- Hydrophobic interactions: 2:Y.111, 2:F.133, 2:Y.158, 2:Y.158, 2:Y.158, 2:I.193, 2:V.195, 2:V.195, 2:F.237, 2:F.237, 2:F.237, 2:L.240
- pi-Stacking: 2:Y.111
W71.26: 17 residues within 4Å:- Chain 6: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain 8: A.24
13 PLIP interactions:13 interactions with chain 6- Hydrophobic interactions: 6:Y.111, 6:F.133, 6:Y.158, 6:Y.158, 6:Y.158, 6:I.193, 6:V.195, 6:V.195, 6:F.237, 6:F.237, 6:F.237, 6:L.240
- pi-Stacking: 6:Y.111
W71.29: 17 residues within 4Å:- Chain a: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain c: A.24
13 PLIP interactions:13 interactions with chain a- Hydrophobic interactions: a:Y.111, a:F.133, a:Y.158, a:Y.158, a:Y.158, a:I.193, a:V.195, a:V.195, a:F.237, a:F.237, a:F.237, a:L.240
- pi-Stacking: a:Y.111
W71.32: 17 residues within 4Å:- Chain e: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain g: A.24
13 PLIP interactions:13 interactions with chain e- Hydrophobic interactions: e:Y.111, e:F.133, e:Y.158, e:Y.158, e:Y.158, e:I.193, e:V.195, e:V.195, e:F.237, e:F.237, e:F.237, e:L.240
- pi-Stacking: e:Y.111
W71.35: 17 residues within 4Å:- Chain i: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain k: A.24
13 PLIP interactions:13 interactions with chain i- Hydrophobic interactions: i:Y.111, i:F.133, i:Y.158, i:Y.158, i:Y.158, i:I.193, i:V.195, i:V.195, i:F.237, i:F.237, i:F.237, i:L.240
- pi-Stacking: i:Y.111
W71.38: 17 residues within 4Å:- Chain m: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain o: A.24
13 PLIP interactions:13 interactions with chain m- Hydrophobic interactions: m:Y.111, m:F.133, m:Y.158, m:Y.158, m:Y.158, m:I.193, m:V.195, m:V.195, m:F.237, m:F.237, m:F.237, m:L.240
- pi-Stacking: m:Y.111
W71.41: 17 residues within 4Å:- Chain q: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain s: A.24
13 PLIP interactions:13 interactions with chain q- Hydrophobic interactions: q:Y.111, q:F.133, q:Y.158, q:Y.158, q:Y.158, q:I.193, q:V.195, q:V.195, q:F.237, q:F.237, q:F.237, q:L.240
- pi-Stacking: q:Y.111
W71.44: 17 residues within 4Å:- Chain u: I.109, Y.111, F.129, F.133, F.135, I.156, Y.158, P.180, S.181, I.182, I.193, V.195, V.198, Y.204, F.237, L.240
- Chain w: A.24
13 PLIP interactions:13 interactions with chain u- Hydrophobic interactions: u:Y.111, u:F.133, u:Y.158, u:Y.158, u:Y.158, u:I.193, u:V.195, u:V.195, u:F.237, u:F.237, u:F.237, u:L.240
- pi-Stacking: u:Y.111
- 15 x MYR: MYRISTIC ACID(Covalent)
MYR.3: 10 residues within 4Å:- Chain D: G.1, A.2, Y.31
- Chain H: V.4, T.27, I.29, Y.31
- Chain O: L.2
- Ligands: MYR.6, MYR.15
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain H- Hydrogen bonds: D:A.2, H:T.27
MYR.6: 10 residues within 4Å:- Chain H: G.1, A.2, Y.31
- Chain L: V.4, T.27, I.29, Y.31
- Chain S: L.2
- Ligands: MYR.3, MYR.9
1 PLIP interactions:1 interactions with chain H- Hydrogen bonds: H:A.2
MYR.9: 10 residues within 4Å:- Chain C: L.2
- Chain L: G.1, A.2, Y.31
- Chain P: V.4, T.27, I.29, Y.31
- Ligands: MYR.6, MYR.12
1 PLIP interactions:1 interactions with chain L- Hydrogen bonds: L:A.2
MYR.12: 10 residues within 4Å:- Chain G: L.2
- Chain P: G.1, A.2, Y.31
- Chain T: V.4, T.27, I.29, Y.31
- Ligands: MYR.9, MYR.15
2 PLIP interactions:1 interactions with chain T, 1 interactions with chain P- Hydrogen bonds: T:T.27, P:A.2
MYR.15: 10 residues within 4Å:- Chain D: V.4, T.27, I.29, Y.31
- Chain K: L.2
- Chain T: G.1, A.2, Y.31
- Ligands: MYR.3, MYR.12
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain T- Hydrogen bonds: D:T.27, T:A.2
MYR.18: 10 residues within 4Å:- Chain 1: V.4, T.27, I.29, Y.31
- Chain 8: L.2
- Chain X: G.1, A.2, Y.31
- Ligands: MYR.21, MYR.30
1 PLIP interactions:1 interactions with chain X- Hydrogen bonds: X:A.2
MYR.21: 10 residues within 4Å:- Chain 1: G.1, A.2, Y.31
- Chain 5: V.4, T.27, I.29, Y.31
- Ligands: MYR.18, MYR.24
- Chain c: L.2
2 PLIP interactions:1 interactions with chain 5, 1 interactions with chain 1- Hydrogen bonds: 5:T.27, 1:A.2
MYR.24: 10 residues within 4Å:- Chain 5: G.1, A.2, Y.31
- Chain 9: V.4, T.27, I.29, Y.31
- Chain W: L.2
- Ligands: MYR.21, MYR.27
2 PLIP interactions:1 interactions with chain 9, 1 interactions with chain 5- Hydrogen bonds: 9:T.27, 5:A.2
MYR.27: 10 residues within 4Å:- Chain 0: L.2
- Chain 9: G.1, A.2, Y.31
- Ligands: MYR.24, MYR.30
- Chain d: V.4, T.27, I.29, Y.31
1 PLIP interactions:1 interactions with chain 9- Hydrogen bonds: 9:A.2
MYR.30: 10 residues within 4Å:- Chain 4: L.2
- Chain X: V.4, T.27, I.29, Y.31
- Ligands: MYR.18, MYR.27
- Chain d: G.1, A.2, Y.31
1 PLIP interactions:1 interactions with chain d- Hydrogen bonds: d:A.2
MYR.33: 10 residues within 4Å:- Ligands: MYR.36, MYR.45
- Chain h: G.1, A.2, Y.31
- Chain l: V.4, T.27, I.29, Y.31
- Chain s: L.2
2 PLIP interactions:1 interactions with chain l, 1 interactions with chain h- Hydrogen bonds: l:T.27, h:A.2
MYR.36: 10 residues within 4Å:- Ligands: MYR.33, MYR.39
- Chain l: G.1, A.2, Y.31
- Chain p: V.4, T.27, I.29, Y.31
- Chain w: L.2
2 PLIP interactions:1 interactions with chain p, 1 interactions with chain l- Hydrogen bonds: p:T.27, l:A.2
MYR.39: 10 residues within 4Å:- Ligands: MYR.36, MYR.42
- Chain g: L.2
- Chain p: G.1, A.2, Y.31
- Chain t: V.4, T.27, I.29, Y.31
1 PLIP interactions:1 interactions with chain p- Hydrogen bonds: p:A.2
MYR.42: 10 residues within 4Å:- Ligands: MYR.39, MYR.45
- Chain k: L.2
- Chain t: G.1, A.2, Y.31
- Chain x: V.4, T.27, I.29, Y.31
1 PLIP interactions:1 interactions with chain t- Hydrogen bonds: t:A.2
MYR.45: 10 residues within 4Å:- Ligands: MYR.33, MYR.42
- Chain h: V.4, T.27, I.29, Y.31
- Chain o: L.2
- Chain x: G.1, A.2, Y.31
2 PLIP interactions:1 interactions with chain h, 1 interactions with chain x- Hydrogen bonds: h:T.27, x:A.2
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hiremath, C.N. et al., Binding of the antiviral drug WIN51711 to the sabin strain of type 3 poliovirus: structural comparison with drug binding in rhinovirus 14. Acta Crystallogr.,Sect.D (1995)
- Release Date
- 1995-06-03
- Peptides
- POLIOVIRUS TYPE 3 (SUBUNIT VP1): AEIMQUY26aeimqu
POLIOVIRUS TYPE 3 (SUBUNIT VP2): BFJNRVZ37bfjnrv
POLIOVIRUS TYPE 3 (SUBUNIT VP3): CGKOSW048cgkosw
POLIOVIRUS TYPE 3 (SUBUNIT VP4): DHLPTX159dhlptx - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1E
1I
1M
1Q
1U
1Y
12
16
1a
1e
1i
1m
1q
1u
1B
2F
2J
2N
2R
2V
2Z
23
27
2b
2f
2j
2n
2r
2v
2C
3G
3K
3O
3S
3W
30
34
38
3c
3g
3k
3o
3s
3w
3D
4H
4L
4P
4T
4X
41
45
49
4d
4h
4l
4p
4t
4x
4
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- hetero-15-15-15-15-mer
- Ligands
- 15 x ILE- SER- GLU- VAL: POLIOVIRUS TYPE 3 (SUBUNIT VP1)(Non-covalent)
- 15 x W71: 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE(Non-covalent)
- 15 x MYR: MYRISTIC ACID(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hiremath, C.N. et al., Binding of the antiviral drug WIN51711 to the sabin strain of type 3 poliovirus: structural comparison with drug binding in rhinovirus 14. Acta Crystallogr.,Sect.D (1995)
- Release Date
- 1995-06-03
- Peptides
- POLIOVIRUS TYPE 3 (SUBUNIT VP1): AEIMQUY26aeimqu
POLIOVIRUS TYPE 3 (SUBUNIT VP2): BFJNRVZ37bfjnrv
POLIOVIRUS TYPE 3 (SUBUNIT VP3): CGKOSW048cgkosw
POLIOVIRUS TYPE 3 (SUBUNIT VP4): DHLPTX159dhlptx - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1E
1I
1M
1Q
1U
1Y
12
16
1a
1e
1i
1m
1q
1u
1B
2F
2J
2N
2R
2V
2Z
23
27
2b
2f
2j
2n
2r
2v
2C
3G
3K
3O
3S
3W
30
34
38
3c
3g
3k
3o
3s
3w
3D
4H
4L
4P
4T
4X
41
45
49
4d
4h
4l
4p
4t
4x
4